Zika reference material, 6/16
June 2016—SeraCare Life Sciences launched its AccuPlex Zika Reference Material aimed to provide a safe, nonreplicative, and fully extractable positive material that covers the entire Zika virus genome.
Webinars and Sponsored Roundtables — Register Now
Wednesday, September 23, 2026. 12 PM-1 PM ET
Roundtable presenters Dr. David Sacks MB, ChB, FRCPath, Chairman, Steering Committee National Glycohemoglobin Standardization Program (NGSP), and Priya Sivaraman, PhD, Senior Technical Product Manager, Tosoh Bioscience
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Thursday, September 24, 2026 11 AM-12 PM CT
This session explores the evolving role of RAS in precision oncology, from the biology of RAS mutations to the expanding landscape of targeted therapies. Through expert presentations, real-world case discussions, and interactive audience polling, participants will examine best practices for RAS biomarker testing across solid tumors, including lung, colorectal, and pancreatic cancers. The session will highlight practical considerations for tissue and liquid biopsy, strategies to address testing gaps, and the importance of multidisciplinary collaboration to ensure timely identification of patients who may benefit from RAS-targeted therapies.
Webinar presenters David Braxton, MD, Chief of Molecular Pathology Services, Hoag Family Cancer Institute & Hoag Memorial Hospital Presbyterian, and Carlos Becerra, MD, Research Director for Medical Oncology, Margaret Given Larkin Endowed Chair for Developmental Cancer Therapeutics, Hoag Memorial Hospital Presbyterian
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, September 30, 2026. 1 PM-1:30 PM ET
Roundtable presenters John Longshore, PhD, Head of Scientific Affairs, Global Oncology Diagnostics, AstraZeneca, and Flora Berisha, MS, Executive Director, Global Head of Diagnostic Partnering and Development, Johnson & Johnson Innovative Medicine, and Mark D. Ewalt, MD, Associate Medical Director for Laboratory Operations, Diagnostic Molecular Pathology, Molecular Diagnostics Service, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, and Isabel Preeshagul, DO, MBS, Thoracic Medical Oncologist, Memorial Sloan Kettering Cancer Center
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Thursday, October 1, 2026 1 PM-2 PM ET
This presentation will explore the value of in-house CGP, offer insights into the benefits and drawbacks of incorporation, and provide information about important practical factors when considering in-house implementation of CGP.
Webinar presenter Allison M. Cushman-Vokoun, MD, PhD, FCAP, Medical Director, Molecular Diagnostics and Personalized Medicine Laboratory, Director, Division of Diagnostic Molecular Pathology and Human Genetics, Henry F. Krous Professor of Pathology, University of Nebraska Medical Center
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, October 20, 2026 11 AM-12 PM ET
Hear experts review the biological and clinical significance of the HER2 expression continuum in breast tissue, providing a clearer understanding of how these variations might impact diagnosis, and discuss the emerging importance of documenting HER2-low and HER2-ultralow categories using a validated IHC assay.
Webinar presenters Keith Wharton, MD, PhD, Global Medical Affairs Leader–Pathology, Roche Diagnostics Solutions, and Hannah Y. Wen, MD, PhD, Director, Breast Pathology Fellowship, Associate Team Leader, Breast Pathology Team, Attending Pathologist, Memorial Sloan Kettering Cancer Center
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Subspecialties
Interactive Product Guides
Marketplace Directory
Processor/stainer for frozen sections, 6/16
June 2016—Presto from Milestone Medical is a fully automated benchtop processor/stainer for high-quality frozen sections.
Siemens, Thermo Fisher strategic relationship, 6/16
June 2016—In a joint effort to provide customers with an advanced solution for molecular testing, Siemens and Thermo Fisher Scientific announced a strategic relationship that includes the integration of Thermo Fisher Scientific’s real-time PCR system into Siemens’ Versant kPCR Molecular Solution.
Rapid Zika virus diagnostic, 6/16
June 2016—Rheonix, in collaboration with New York University College of Dentistry, has received funding from a Small Business Innovation Research Phase I/II Fast-track grant from the National Institute of Dental and Craniofacial Research of the National Institutes of Health to develop a rapid diagnostic for Zika virus infection.
FISH probes for glial tumors, 6/16
June 2016—Oxford Gene Technology launched its CE-IVD labeled Cytocell Aquarius 1p36/1q25 and 19q13/19p13 Deletion Probe Kit, a fluorescence in situ hybridization kit for the reliable investigation of glial tumors.
NGS assays for hematological malignancy profiling, 6/16
June 2016—ArcherDX announced three targeted next-generation sequencing assays to capture and identify known and novel gene fusions, point mutations, and relative expression levels in myeloid and lymphoid origin malignancies. The Archer FusionPlex Blood Cancer panels use Archer’s proprietary Anchored Multiplex PCR to detect known and novel fusions from RNA.
Cell-based imaging software, 6/16
June 2016—BioTek launched the Gen5 3.0 data analysis software for its imaging and microplate detection instruments.
Binding Site, Rockland enter distribution agreement, 6/16
June 2016—The Binding Site Group has entered into an exclusive, definitive agreement with Rockland Immunochemicals to grant Rockland global distribution rights for Binding Site’s line of animal-focused radial immunodiffusion test kits. The RID immunoassay kits incorporate monospecific antibodies in an agarose gel to provide accurate quantitation.
Mopec, Milestone sign agreement, 6/16
June 2016—Mopec has signed an exclusive agreement to feature Milestone’s MacroPath pro-x macro digital imaging system with its MB800 grossing station.
Agena and Horizon partner, 6/16
June 2016—Agena Bioscience and Horizon Discovery Group announced a supply and distribution agreement to launch iPlex reference standards for performance verification of oncology assays used on the MassArray System.